跳轉至內容
Merck
  • Pseudotumor cerebri in a child treated with acitretin: a rare occurrence.

Pseudotumor cerebri in a child treated with acitretin: a rare occurrence.

Indian journal of pharmacology (2013-04-02)
Somenath Sarkar, Kapildev Das, Soumyajit Roychoudhury, Arpit Shrimal
摘要

Pseudotumor cerebri (PTC) is a rare neurological disorder characterized by increased intracranial pressure in absence of any intra-cranial space-occupying lesion. It is mostly due to impairment of drainage of CSF from arachnoid villi. Clinically pseudotumor cerebri presents with headache, diplopia, nausea, vomiting, papilloedema and if treatment is delayed, may lead to blindness. Females of childbearing age group, endocrinal abnormalities and ingestion of certain drugs have been reported to be associated with pseudotumor cerebri. However, it's occurrence in relation to acitretin ingestion has not been reported on pubmed database. Here we present a case where significant temporal association of acitretin intake with PTC was found in a child who was being treated with this medication for recalcitrant pustular psoriasis. The case is reported for its rarity in occurrence and associated significant morbidity including visual loss if not diagnosed and treated immediately. According to Naranjo ADR Causality scale of adverse drug reaction, the association of PTC due to acitretin in our case was probable.

材料
產品編號
品牌
產品描述

USP
Acitretin Related Compound A, United States Pharmacopeia (USP) Reference Standard